FDA D AND DRUG ADMINISTRATION (FDA) r Biologics Evaluation and Research (CBER) eting of the Vaccines and Related Biological Products Advisory Committee 1. Pfizer has proposed a plan for contir blinded, placebo-controlled follow-up ongoing trials if the vaccine were ma available under EUA. Please discuss plan, including how loss of blinded, p controlled follow-up in ongoing trials addressed. FDA DISCUSSION 2. Please discuss any gaps in plans de 這是美國 FDA審核輝瑞 全程直播 專家論述錄影留證 這是台灣 審核高端 陳時中表示 直播侵害專家權益 此篇相同回報者之文章列表

Order By:

7294 articles

PrevNext

PrevNext